Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Homoserine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLUL | P15104 | 1/20 | 0.53 |
| ▸ | GRM8 | O00222 | 2/20 | 0.52 |
| ▸ | GRM6 | O15303 | 2/20 | 0.52 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.52 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.52 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.50 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.50 |
| ▸ | GSR | P00390 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 1/20 | 0.50 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.50 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.50 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.50 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.50 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.50 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.50 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Homoserine SCHEMBL60700 | 1.00 | GLUL (0.53) | GLULGRM8GRM6GRM7GRM4 | |
| Homoserine SCHEMBL27518745 | 1.00 | GLUL (0.53) | GLULGRM8GRM6GRM7GRM4 | |
| Homoserine SCHEMBL6447119 | 0.90 | GSR (0.59) | GRM8GRM6GRM7GRM4GRIN2D | |
| Homoserine SCHEMBL29649 | 0.90 | — | — | |
| Homoserine SCHEMBL60060 | 0.90 | — | — | |
| Homoserine SCHEMBL4944178 | 0.90 | GSR (0.59) | GRM8GRM6GRM7GRM4GRIN2D | |
| Homoserine SCHEMBL6446994 | 0.90 | GSR (0.59) | GRM8GRM6GRM7GRM4GRIN2D | |
| Homoserine SCHEMBL29648 | 0.90 | — | — | |
| Homoserine SCHEMBL23748103 | 0.87 | — | — | |
| Homoserine SCHEMBL9471942 | 0.87 | GSR (0.56) | GRM8GRM6GRM7GRM4GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2851421-B1 | USEFUL MICROORGANISM, AND METHOD FOR PRODUCING SUBSTANCE OF INTEREST | KAO CORP (JP) | 2018-11-28 | — | — | EP | claimed |
| US-20150197775-A1 | USEFUL MICROORGANISM AND METHOD FOR PRODUCING SUBSTANCE OF INTEREST | GENARIS, INC. (JP) | 2015-07-16 | — | — | US | claimed |
| EP-2851421-A1 | USEFUL MICROORGANISM, AND METHOD FOR PRODUCING DESIRED SUBSTANCE | Genaris, Inc. (JP) | 2015-03-25 | — | — | EP | claimed |
| CN-104379729-A | Useful microorganism, and method for producing desired substance | GENARIS INC | 2015-02-25 | — | — | CN | claimed |
| EP-0338790-A2 | Production of homoserine and its derivatives such as threonine derivatives and methionine precursors | BIOTECHNICA INTERNATIONAL, INC. (US) | 1989-10-25 | — | — | EP | claimed |
| CN-119979428-A | Recombinant bacterium for synthesizing L-homoserine and L-threonine by using fatty acid and application thereof | 微元合成生物技术(北京)有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-111944781-A | Mutant homoserine kinase and application thereof | 廊坊梅花生物技术开发有限公司 | 2020-11-17 | — | — | CN | disclosed |
| US-10781461-B2 | Useful microorganism and method for producing substance of interest | KAO CORPORATION (JP) | 2020-09-22 | — | — | US | disclosed |
| US-20200294617-A1 | A GRAPH-BASED CONSTANT-COLUMN BICLUSTERING DEVICE AND METHOD FOR MINING GROWTH PHENOTYPE DATA | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2020-09-17 | — | — | US | disclosed |
| EP-3701532-A1 | A GRAPH-BASED CONSTANT-COLUMN BICLUSTERING DEVICE AND METHOD FOR MINING GROWTH PHENOTYPE DATA | King Abdullah University Of Science And Technology (SA) | 2020-09-02 | — | — | EP | disclosed |
| CN-104379729-B | Process for producing useful microorganism and target substance | 花王株式会社 | 2020-07-21 | — | — | CN | disclosed |
| CN-110267655-A | The treatment method of amino acid composition and muscle disease and illness | 胺细拉健康公司 | 2019-09-20 | — | — | CN | disclosed |
| CN-1226931-A | Escherichia coli strains and preparation thereof and use thereof in fermentation process for production of L-threonine | ARCHER DANIELS MIDLAND CO (US) | 1999-08-25 | — | — | CN | disclosed |
| US-5939307-A | GENETIC ENGINEERING | THE ARCHER-DANIELS-MIDLAND COMPANY (US) | 1999-08-17 | — | — | US | disclosed |
| EP-0917578-A1 | NOVEL STRAINS OF $i(ESCHERICHIA COLI), METHODS OF PREPARING THE SAME AND USE THEREOF IN FERMENTATION PROCESSES FOR L-THREONINE PRODUCTION | ARCHER-DANIELS-MIDLAND COMPANY (US) | 1999-05-26 | — | — | EP | disclosed |
| WO-1998004715-A9 | NOVEL STRAINS OF ESCHERICHIA COLI, METHODS OF PREPARING THE SAME AND USE THEREOF IN FERMENTATION PROCESSES FOR L-THREONINE PRODUCTION | — | 1998-05-22 | — | — | WO | disclosed |
| WO-1998004715-A1 | NOVEL STRAINS OF ESCHERICHIA COLI, METHODS OF PREPARING THE SAME AND USE THEREOF IN FERMENTATION PROCESSES FOR L-THREONINE PRODUCTION | ARCHER-DANIELS-MIDLAND COMPANY (US) | 1998-02-05 | — | — | WO | disclosed |
| WO-1997027851-A1 | L-HOMOSERINE AND L-HOMOSERINE LACTONE AS BACTERIOSTATIC AGENTS FOR M. TUBERCULOSIS AND M. BOVIS | THE JOHNS-HOPKINS UNIVERSITY (US) | 1997-08-07 | — | — | WO | disclosed |
| US-5641660-A | Glutamicum threonine biosynthetic pathway | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1997-06-24 | — | — | US | disclosed |
| US-5128255-A | Method and a preparation to select for transfected DNA in mammalian cells | GENTEST CORPORATION (US) | 1992-07-07 | — | — | US | disclosed |